Table 6.
Clinical Events | Rhythm Control (%) | Rate Control (%) | P Value |
---|---|---|---|
Any clinical event | 483/2809 (17.2) | 405/2225 (18.2) | 0.352 |
Cardiovascular death | 24/2804 (0.9) | 61/2213 (2.8) | <0.001 |
Myocardial infarction | 14/2785 (0.5) | 20/2175 (0.9) | 0.078 |
Stroke or transient ischemic attack | 46/2784 (1.7) | 60/2179 (2.8) | 0.008 |
Hospitalization for cardiovascular event | 465/2793 (16.6) | 366/2195 (16.7) | 0.891 |
Hospitalization or increased duration of hospital stay | |||
Due to arrythmia or proarrhythmia | 314/2790 (11.3) | 159/2179 (7.3) | <0.001 |
Due to other cardiovascular events or interventions | 190/2791 (6.8) | 204/2182 (9.3) | 0.001 |
Due to major complications of ablative procedure | 15/2786 (0.5) | 14/2171 (0.6) | 0.626 |
Occurrence of clinical outcomes was counted between baseline and 12 months in patients with AF or a history of AF, excluding permanent AF or transient/reversible causes of AF. Cardiovascular death recorded at 12 months includes any events reported until the end of the 15th month after baseline. AF indicates atrial fibrillation; RECORD‐AF, The global Registry on Cardiac rhythm disorders assessing the control of Atrial Fibrillation.